J. Heffernan

Aqueous stability of recombinant human thrombopoietin as a function of processing schemes.

L. Kreilgaard, G. Rosenberg, H. J. Clarke, 1996, Journal of pharmaceutical sciences.

Safety of Recombinant Human Factor XIII in a Cynomolgus Monkey Model of Extracorporeal Blood Circulation

J. Hensler, R. Ponce, M. Rogge, 2005, Toxicologic pathology.

Preclinical Safety and Pharmacokinetics of Recombinant Human Factor XIII

R. Ponce, K. Lewis, S. Pederson, 2005, Toxicologic pathology.

Consideration of conformational transitions and racemization during process development of recombinant glucagon-like peptide-1.

J. Krakover, J. Chang, L. Kreilgaard, 1998, Journal of pharmaceutical sciences.

Interleukin-21 Enhances Rituximab Activity in a Cynomolgus Monkey Model of B Cell Depletion and in Mouse B Cell Lymphoma Models

R. Ponce, C. Krejsa, D. Foster, 2013, PloS one.

Preclinical safety of recombinant human thrombin.

Erika Giste, R. Ponce, S. Pederson, 2007, Regulatory toxicology and pharmacology : RTP.